Protocol No
CVC-BOSTONSCI-SIMPLAAFY
Staff Member
Marcie Berger
Phase
N/A
Summary
This project is being done to compare three medications used after the WATCHMAN FLX Pro device is placed for atrial fibrillation (AFib); non-vitamin K antagonist oral anticoagulation (NOACs), aspirin, and dual-antiplatelet therapy (DAPT).
Objective
SIMPLAAFY Clinical Trial
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov